Form 8-K - Current report:
SEC Accession No. 0001477932-17-000821
Filing Date
2017-02-16
Accepted
2017-02-16 07:00:15
Documents
2
Period of Report
2017-02-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctix_8k.htm 8-K 12810
2 PRESS RELEASE ctix_ex991.htm EX-99.1 19277
  Complete submission text file 0001477932-17-000821.txt   33310
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

EIN.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37357 | Film No.: 17616423
SIC: 2834 Pharmaceutical Preparations